Innovent Biologics Inc
HKEX:1801
Innovent Biologics Inc
EPS (Diluted)
Innovent Biologics Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Innovent Biologics Inc
HKEX:1801
|
EPS (Diluted)
¥0
|
CAGR 3-Years
4%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
EPS (Diluted)
-¥4
|
CAGR 3-Years
17%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-5%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
EPS (Diluted)
¥0
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
EPS (Diluted)
¥3
|
CAGR 3-Years
10%
|
CAGR 5-Years
24%
|
CAGR 10-Years
43%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
EPS (Diluted)
¥5
|
CAGR 3-Years
46%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
See Also
What is Innovent Biologics Inc's EPS (Diluted)?
EPS (Diluted)
-0.7
CNY
Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's EPS (Diluted) amounts to -0.7 CNY.
What is Innovent Biologics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
48%
Over the last year, the EPS (Diluted) growth was 55%. The average annual EPS (Diluted) growth rates for Innovent Biologics Inc have been 4% over the past three years , 48% over the past five years .